Navigation Links
'Left-handed iron corkscrews' point the way to new weapon in battle against superbugs like MRSA
Date:11/28/2011

Scientists at the University of Warwick have taken inspiration from corkscrew structures found in nature to develop a new weapon in the fight against infections like E-coli and MRSA.

Researchers have created a new synthetic class of helix-shaped molecules which they believe could be a key tool in the worldwide battle against antibiotic resistance.

By twisting molecules around iron atoms they have created what they term 'flexicates' which are active against MRSA and E-coli - but which also appear to have low toxicity, reducing the potential for side effects if used in treatment.

The work is published in Nature Chemistry.

The new structures harness the phenomenon of 'chirality' or 'handedness' whereby the corkscrew molecules could be left-handed or right-handed.

By making the most effective 'hand' to attack a specific disease, the University of Warwick research paves the way towards a more targeted approach to killing pathogens.

In the case of E-coli and MRSA, it is the left 'hand' which is most effective.

Professor Peter Scott of the University of Warwick's chemistry department said although this particular study concentrated on flexicates' activity against MRSA and E-coli, the new method of assembly could also result in new treatments for other diseases.

"It's a whole new area of chemistry that really opens up the landscape to other practical uses.

"These new molecules are synthetically flexible, which means that with a bit of tweaking they can be put to use against a whole host of different diseases, not just bugs like MRSA which are rapidly developing resistance to traditional antibiotics.

"Flexicates are also easier to make and produce less waste than many current antibiotics."

Scientists have long been able to copy nature's corkscrew-shaped molecules in man-made structures known as helicates but they have thus far not been able to use them in fighting diseases.<
'/>"/>

Contact: Anna Blackaby
a.blackaby@warwick.ac.uk
44-247-657-5910
University of Warwick
Source:Eurekalert

Page: 1 2

Related medicine news :

1. CU-Boulder led study of smoking twins points to growing influence of genetic factors
2. Life challenges prevent those with lupus from keeping doctors appointments
3. Hard times during adolescence point to health problems later in life
4. Could Airway Abnormality Point to Autism?
5. Calorie count plus points based on added sugars, sodium, and saturated and trans fats recommended as new front-of-package nutrition labeling system
6. 3 factors could point to your fate after surgery
7. Evidence points to potential roles for cognitive rehabilitation therapy in treating traumatic brain injury, but further research needed
8. Gauging General Health as Poor May Point to Dementia Risk
9. Experts Point Out Signs of Dangerous Heart Rhythm
10. Novel research set to pinpoint risk of heart attacks and strokes
11. Key signal that prompts production of insulin-producing beta cells points way toward diabetes cure
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... the University of Murcia have studied the changes ... a personality trait that causes difficulties in inhibiting ... and leads to unplanned actions without considering the ... indicator for predicting the risk of behavioural problems. ... the University of Murcia analyses whether the connectivity ...
(Date:7/22/2014)... CyraCom has been ranked as North ... translation and interpreting industry. Released June 2014 by the ... "The Language Services Market: 2014," also ranked CyraCom as ... up two spots from 2013. , In 2013, Common ... provide interpretation services – a subset of the language ...
(Date:7/22/2014)... 2014 The Muscular Dystrophy Association (MDA) and ... MUSCLE UP campaign that will raise funds to ... million Americans fighting muscle disease. , As part ... Jiffy Lube service centers through Sept. 1, 2014 to make ... make progress in the fight for muscle health. Since 2012, ...
(Date:7/22/2014)... The Restful Jaw Company announces its latest ... ®. The FDA-registered external device is clinically proven to ... fatigue and soreness during dental procedures. As such, patients ... do not need to take breaks or terminate procedures ... a vital solution in helping more than 31 million ...
(Date:7/22/2014)... Alan Mozes HealthDay Reporter ... drug already used to treat moderate-to-severe allergic asthma appears to ... helped by standard medications, new research suggests. The prescription ... hives, following U.S. Food and Drug Administration approval earlier this ... when Xolair is taken at a high dose for a ...
Breaking Medicine News(10 mins):Health News:Children's impulsive behaviour is related to their brain connectivity 2Health News:CyraCom Ranked Among the World’s Largest Language Service Providers 2Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 2Health News:Jiffy Lube® Supports Fight Against Muscle Disease with Third Annual MUSCLE UP® Campaign 3Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 2Health News:Introducing the Restful Jaw – The Only Device Designed to Protect the Patient’s Jaw 3Health News:Asthma Drug May Help Those With Chronic Hives 2Health News:Asthma Drug May Help Those With Chronic Hives 3
... Indian Railways handed over the new five state-of-the-art coach ... train, to Impact India Foundation here today. Speaking on ... said that since 1991, Impact India Foundation with the ... of cost to nearly 4,50,000 persons in remote and ...
... McCartney is pregnant again, just 7 months after giving birth to ... expecting her third child with husband Alasdhair Willis before the end ... legend dad Sir Paul McCartney is thrilled after hearing the news. ... has been getting him through the tough times. He would be ...
... tobacco industrys deceptive practices have been aggressively quashed through ... Ibrahim , co-author of an analysis in the August ... ,In the article, Ibrahim tracks the rise and ... for the past 40 years. She chronicles industry strategies ...
... structure of a key molecule called 'P2X receptor' that ... might lead to the development of painkillers for recurring ... by a team of researchers including Dr Chris Thompson, ... University of Manchester. ,Researchers examined slime moulds, ...
... the capacity of short-term memory is a strong predictor of ... ,A study conducted by them has shown that an ... time, but people with high IQ levels can remember more ... Vogel of the university conducted laboratory experiments to test their ...
... without fear of prosecution in one English city's pubs ... national ban, the local council admitted Wednesday . ... can spark up knowing that bureaucrats cannot impose the ... to get enforcement powers in time for July 1, ...
Cached Medicine News:Health News:New Lifeline Express Train Inaugurated 2Health News:Tobacco Industry Promotes Antismoking Campaigns 2Health News:Tobacco Industry Promotes Antismoking Campaigns 3Health News:Blunder Leaves Smoking Ban Up in Smoke in Stoke 2
(Date:7/22/2014)... 2014 Elekta (NSE:EKTAb) and Royal Philips ... NHS Foundation Trust ( Manchester, UK ), ... mission is to develop the clinical value of an ... Such a system would, in principle, improve the practice ... "The Christie was an essential participant in ...
(Date:7/22/2014)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... of patients in its ongoing Phase 2 trial (Study ... the revised clinical protocol agreed to with the FDA ... Halozyme,s proprietary recombinant human hyaluronidase under development for the ... "Our diligent effort to rapidly re-initiate patient enrollment ...
(Date:7/22/2014)... July 22, 2014  Neurotrope Bioscience, Inc., a subsidiary ... exclusive license agreement with the Icahn School of Medicine ... Mount Sinai ) to utilize its proprietary information ... the treatment of Niemann-Pick Type C Disease (NPC), a ... Alzheimer-like symptoms. The license also covers other diseases and ...
Breaking Medicine Technology:The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 2The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 3The Christie Hospital joins Elekta and Philips research consortium to develop MRI-guided radiation therapy system for cancer treatment 4Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 2Halozyme Resumes Patient Enrollment And Dosing In PEGPH20 Clinical Program In Pancreatic Cancer 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 2Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 3Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 4Neurotrope Enters Collaborative Agreement with Icahn School of Medicine at Mount Sinai for use of Bryostatin-1 in the Treatment of Niemann-Pick Disease Type C 5
... DATATRAK International, Inc. (OTCQX: DATA), a technology and services ... trials industry, today announced that it has been awarded ... Organization (CRO) in India, with which the Company had ... order to execute a Phase II study for the ...
... 8, 2011 Vanda Pharmaceuticals Inc. (Nasdaq: ... has granted orphan drug designation for tasimelteon, an oral ... for Non-24-Hour Sleep/Wake Disorder (N24HSWD) in blind individuals with ... the designation that the Committee for Orphan Medicinal Products ...
Cached Medicine Technology:DATATRAK Awarded First Study With Kreara Solutions 2DATATRAK Awarded First Study With Kreara Solutions 3Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 2Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 3Vanda Pharmaceuticals Receives Orphan Drug Designation in Europe for tasimelteon 4
Provides effective stretching of the plantar fascia and Achilles Tendon with bi-lateral dorsiflexion assist straps that allow the patient to adjust the degree of flexion to their individual requireme...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... to treat Achilles tendonitis and plantar fasciitis. Using ... and in back of the heel, the AirHeel ... reduce swelling and enhance circulation. The AirHeel is ... to apply just slip it on like ...
... of controlled compression and cold, the Foot ... anatomically designed cuff provides complete foot coverage ... as a single cuff, or with a ... disk). The Cooler is available separately and ...
Medicine Products: